83 related items for PubMed ID: 9589380
41. Effect of isradipine on cyclosporin A-related hypertension.
van den Dorpel MA, Zietse R, Ijzermans JN, Schalekamp MA, Weimar W.
Blood Press Suppl; 1994; 1():50-3. PubMed ID: 8205301
[Abstract] [Full Text] [Related]
42. Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia.
Sugioka N, Takai M, Yoshida K, Yasuda K, Fukushima K, Kokuhu T, Okamoto M, Yoshimura N, Takada K.
J Clin Pharm Ther; 2010 Jun; 35(3):323-32. PubMed ID: 20831533
[Abstract] [Full Text] [Related]
43. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
Sugioka N, Fujimoto K, Tanaka Y, Fukushima K, Ito Y, Kokuhu T, Okamoto M, Yoshimura N, Takada K.
Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
[Abstract] [Full Text] [Related]
44. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
Berthoux FC, Guerin C, Burgard G, Berthoux P, Alamartine E.
Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
[No Abstract] [Full Text] [Related]
45.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
46.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
47.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
50. Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.
Shinohara H, Shimada M, Ogasawara T, Morine Y, Ikemoto T, Imura S, Fujii M.
Dig Dis Sci; 2007 Oct; 52(10):2490-6. PubMed ID: 17431772
[Abstract] [Full Text] [Related]
51. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose.
Molpeceres J, Chacón M, Guzmán M, Aberturas MR, Berges L.
Int J Pharm; 2000 Mar 20; 197(1-2):129-41. PubMed ID: 10704800
[Abstract] [Full Text] [Related]
52. Blood and plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients.
Mendonza AE, Gohh RY, Akhlaghi F.
Clin Pharmacokinet; 2008 Mar 20; 47(11):733-42. PubMed ID: 18840028
[Abstract] [Full Text] [Related]
53. Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
Varela MC, Guzmán M, Molpeceres J, del Rosario Aberturas M, Rodríguez-Puyol D, Rodríguez-Puyol M.
Eur J Pharm Sci; 2001 Feb 20; 12(4):471-8. PubMed ID: 11231114
[Abstract] [Full Text] [Related]
54. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
Vanrenterghem Y, Waer M, De Keyser P, Roels L, Michielsen P.
Transplant Proc; 1988 Jun 20; 20(3 Suppl 3):615-7. PubMed ID: 3291296
[No Abstract] [Full Text] [Related]
55. Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients.
Nakamura T, Kakumoto M, Sakaeda T, Nagahiro K, Ohmichi R, Yamashita K, Nishiguchi K, Hirai M, Okumura K.
Biol Pharm Bull; 2001 Jun 20; 24(6):683-7. PubMed ID: 11411559
[Abstract] [Full Text] [Related]
56.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
57. Immunosuppression with polyunsaturated fatty acids in renal transplantation.
McHugh MI, Wilkinson R, Elliott RW, Field EJ, Dewar P, Hall RR, Taylor RM, Uldall PR.
Transplantation; 1977 Oct 20; 24(4):263-7. PubMed ID: 335584
[Abstract] [Full Text] [Related]
58. Pharmacokinetics of cyclosporine pre- and post-liver transplantation.
Hebert MF, Wacher VJ, Roberts JP, Benet LZ.
J Clin Pharmacol; 2003 Jan 20; 43(1):38-42. PubMed ID: 12520626
[Abstract] [Full Text] [Related]
59. Marine n-3 Polyunsaturated Fatty Acids and Cellular Senescence Markers in Incident Kidney Transplant Recipients: The Omega-3 Fatty Acids in Renal Transplantation (ORENTRA) Randomized Clinical Trial.
Chan J, Eide IA, Tannæs TM, Waldum-Grevbo B, Jenssen T, Svensson M.
Kidney Med; 2021 Jan 20; 3(6):1041-1049. PubMed ID: 34939013
[Abstract] [Full Text] [Related]
60. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.
Chatterjee SN, Smith R, Fine S, Schulman B, Fine RN.
Transplant Proc; 1981 Mar 20; 13(1 Pt 2):709-11. PubMed ID: 7022938
[No Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
